Evidence map›Paper›PMID 31171848›Full record

ArticleThe Journal of antibiotics2019

Stable pantothenamide bioisosteres: novel antibiotics for Gram-positive bacteria.

Patrick A M Jansen, Danique A van der Krieken, Peter N M Botman, Richard H Blaauw, Lorenzo Cavina, Eline M Raaijmakers, Erik de Heuvel, Julia Sandrock, Lian J Pennings, Pedro H H Hermkens and 3 more

Abstract read
In one paragraph

Article in The Journal of antibiotics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Mining Fatty Acid Biosynthesis for New Antimicrobials.Annual review of microbiology · 2022
    Review
  9. Article
  10. Review
  11. The Pathophysiological Role of CoA.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Patrick A M JansenDepartment of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands. Patrick.jansen@radboudumc.nl.
Danique A van der KriekenDepartment of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.
Peter N M BotmanChiralix, Nijmegen, The Netherlands.
Richard H BlaauwChiralix, Nijmegen, The Netherlands.
Lorenzo CavinaChiralix, Nijmegen, The Netherlands.
Eline M RaaijmakersChiralix, Nijmegen, The Netherlands.
Erik de HeuvelChiralix, Nijmegen, The Netherlands.
Julia SandrockChiralix, Nijmegen, The Netherlands.
Lian J PenningsDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
Pedro H H HermkensHermkens Pharma Consultancy, Oss, The Netherlands.
Patrick L J M ZeeuwenDepartment of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.
Floris P J T RutjesInstitute for Molecules and Materials, Radboud University, Nijmegen, The Netherlands.
Joost SchalkwijkDepartment of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands. Joost.schalkwijk@radboudumc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of multidrug resistant bacteria has prioritized the development of new antibiotics. N-substituted pantothenamides, analogs of the natural compound pantetheine, were reported to target bacterial coenzyme A biosynthesis, but these compounds have never reached the clinic due to their instability in biological fluids. Plasma-stable pantothenamide analogs could overcome these issues. We first synthesized a number of bioisosteres of the prototypic pantothenamide N7-Pan. A compound with an inverted amide bond (CXP18.6-012) was found to provide plasma-stability with minimal loss of activity compared to the parent compound N7-Pan. Next, we synthesized inverted pantothenamides with a large variety of side chains. Among these we identified a number of novel stable inverted pantothenamides with selective activity against Gram-positive bacteria such as staphylococci and streptococci, at low micromolar concentrations. These data provide future direction for the development of pantothenamides with clinical potential.

Indexed as

Anti-Bacterial AgentsDrug StabilityMicrobial Sensitivity TestsMolecular StructureStaphylococcusStreptococcusAnti-Bacterial Agents

Identifiers

PMID31171848
PMCPMC6760626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.